Laila S. Agrawal
Expertise in
8
conditions

Dr. Laila S. Agrawal

Hematology | Oncology
Norton Cancer Institute Downtown
676 S Floyd St, Ste 200, 
Louisville, KY 
Accepting New Patients
17 Years of Experience
Expertise in
8
conditions
Norton Cancer Institute Downtown
676 S Floyd St, Ste 200, 
Louisville, KY 

Overview

Laila Agrawal is a Hematologist and an Oncologist practicing medicine in Louisville, Kentucky. She has been practicing medicine for over 17 years.

Dr. Agrawal is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.

Dr. Agrawal is board certified in American Board Of Internal Medicine, Internal Medicine - 2012. She is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 3 clinical trials. Dr. Agrawal is currently accepting new patients.

Graduate Institution

Indiana University School Of Medicine, Doctor Of Medicine, 2009

Residency

University of Washington School of Medicine, Internal Medicine, 2012

Specialties

Hematology
Oncology

Licenses

Hospitalist in MO

Board Certifications

American Board Of Internal Medicine, Internal Medicine - 2012

Fellowships

Vanderbilt University Medical Center GME, Hematology and Medical Oncology, 2016

Hospital Affiliations

Norton Hospitals, Inc
Norton Clark Hospital
Baptist Health Floyd

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MHS
  • EPO
SummaCare
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Norton Cancer Institute Downtown
676 S Floyd St, Ste 200, Louisville, KY 40202
Other Locations
Norton Cancer Institute - Brownsboro
4955 Norton Healthcare Boulevard, Louisville, KY 40241
Norton Cancer Institute - Downtown
676 South Floyd Street, Louisville, KY 40202
Norton Cancer Institute Women's Cancer Center
234 East Gray Street, Suite 154, Louisville, KY 40202

Additional Areas of Focus

Dr. Agrawal has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug
Study Drugs: Tucatinib, Trastuzumab, Pertuzumab
Study Phase: Phase 3
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients Who Were Previously Treated With T-DXd
Enrollment Status: Active_not_recruiting
Publish Date: March 09, 2026
Intervention Type: Drug
Study Drug: ARX788
Study Phase: Phase 2
A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive/HER2-negative (HR+/HER2-) Advanced or Metastatic Breast Cancer
A Phase I/II Dose Escalation and Expansion Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK525762 in Combination With Fulvestrant in Subjects With Hormone Receptor-positive/HER2-negative (HR+/HER2-) Advanced or Metastatic Breast Cancer
Enrollment Status: Terminated
Publish Date: August 29, 2024
Intervention Type: Drug
Study Drugs: GSK525762, Fulvestrant
Study Phase: Phase 1
View 2 Less Clinical Trials

10 Total Publications

Women's Insights on Sexual Health After Breast Cancer (WISH-BREAST) Survey.
Women's Insights on Sexual Health After Breast Cancer (WISH-BREAST) Survey.
Journal: JCO oncology practice
Published: July 07, 2025
Similar Doctors
Expertise in
22
conditions
Dr. Ashok B. Raj
Hematology | Oncology
Expertise in
22
conditions
Dr. Ashok B. Raj
Hematology | Oncology
Referral may be required

Norton Children's Sleep Medicine-Novak Center

411 E Chestnut St, 
Louisville, KY 
 (0.2 miles away)
502-588-3600
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Ashok Raj is a Hematologist and an Oncologist practicing medicine in Louisville, Kentucky. Dr. Raj is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Hemoglobin SC Disease, Immune Thrombocytopenic Purpura (ITP), Bone Marrow Aspiration, and Lithotripsy. Dr. Raj is currently accepting new patients.

Expertise in
52
conditions
Dr. John L. Huber
Hematology | Oncology
Expertise in
52
conditions
Dr. John L. Huber
Hematology | Oncology
Referral may be required

Baptist Health Lagrange Kresge Pharmacy

4003 Kresge Way Ste 500, 
Louisville, KY 
 (5.2 miles away)
502-897-1166
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Huber is a Hematologist and an Oncologist practicing medicine in Louisville, Kentucky. Dr. Huber is highly rated in 52 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Chronic Lymphocytic Leukemia (CLL), Thrombocytopenia, and Bone Marrow Aspiration. Dr. Huber is currently accepting new patients.

Expertise in
65
conditions
Dr. Donald E. Goodin
Hematology | Oncology
Expertise in
65
conditions
Dr. Donald E. Goodin
Hematology | Oncology
Referral may be required

Hardin Memorial Health Cancer Studies

521 Robinbrooke Blvd, 
Elizabethtown, KY 
 (37.1 miles away)
270-706-1535
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Donald Goodin is a Hematologist and an Oncologist practicing medicine in Elizabethtown, Kentucky. Dr. Goodin is highly rated in 65 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Lung Cancer. Dr. Goodin is currently accepting new patients.

Frequently Asked Questions about Dr. Laila S. Agrawal

How do I make an appointment with Dr. Laila S. Agrawal?

You can book an appointment with Dr. Laila S. Agrawal by calling their office at 502-394-6350. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Laila S. Agrawal a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Laila S. Agrawal is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Laila S. Agrawal specialize in?

While Dr. Laila S. Agrawal is a Hematology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Laila S. Agrawal participate in research or clinical trials?

Yes. Dr. Laila S. Agrawal has published 10 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Laila S. Agrawal's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Laila S. Agrawal accept my insurance?

Dr. Laila S. Agrawal accepts most major insurance plans, including Aetna and Ambetter. We recommend calling the office directly at 502-394-6350 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Agrawal's expertise for a condition
ConditionClose
    View All 48 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile